TZ LIMITED — Share Issue/Capital Change 2010

Jul 6, 2010

TZ Limited ABN 26 073 979 272

==> picture [55 x 49] intentionally omitted <==

7 July 2010

Lodged by ASX Online

The Manager Company Announcements Office ASX Ltd. Level 4, 20 Bridge Street Sydney, NSW 2000

Dear Sir/Madam

APPENDIX 3B - CORRECTION

TZ Limited (the "Company" ) refers to its recent announcement with respect to Rights and Options issued today under the Company’s Director and Executive Equity Plan. That announcement and the Appendix 3B attached to it contained typographical errors. The Company confirms that it has today issued 5,250,000 Options under the Company’s Director and Executive Equity Plan, not 6,000,000 Options as stated in the Company’s previous announcement.

A corrected Appendix 3B is attached in respect of the Rights and Options issued by the Company today.

Yours faithfully,

TZ LIMITED

==> picture [204 x 56] intentionally omitted <==

Mark Bouris Chairman

Chicago (Operational Headquarters)

Sydney (Registered Office) Level 11, 1 Chifley Square Sydney, NSW 2000 Australia

ASX: TZL Web: www.tz.net Email: info@tz.net

520 West Erie Street, Suite 100 Chicago, IL 60654 United States

Rule
2.7,
3.10.3,
3.10.4,
3.10.5

Appendix
3B

New
issue
announcement, application
for
quotation
of
additional
securities and
agreement

Information
or
documents
not
available
now
must
be
given
to
ASX
as
soon
as
available.

Information
and documents
given
to
ASX
become
ASX’s
property
and
may
be
made
public.

Introduced
1/7/96.

Origin:
Appendix
5.

Amended
1/7/98,
1/9/99,
1/7/2000,
30/9/2001,
11/3/2002,
1/1/2003,
24/10/2005.

Name
of
entity

TZ
LIMITED

ABN

26
073
979
272

We
(the
entity)
give
ASX
the
following
information.

Part
1
­
All
issues

You
must
complete
the
relevant
sections
(attach
sheets
if
there
is
not
enough
space).

1 +Class of+securities issued or to beissued 2 Numberof+securitiesissuedorto beissued(ifknown)ormaximum numberwhichmaybeissued 3 Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price anddatesforconversion)	1.Rights(underDirectorandExecutive EquityPlan). 2.DirectorOptions(underDirectorand ExecutiveEquityPlan)	1.Rights(underDirectorandExecutive EquityPlan). 2.DirectorOptions(underDirectorand ExecutiveEquityPlan)
	1.2,880,000Rights. 2.5,250,000Options.
	1.Rights Theprincipaltermsoftherightsare: • An entitlement to one fully paid ordinaryshareinTZLimitedforeach Rightthatisexercised. • Thefirsttrancheof1,480,000Rights vestimmediatelyuponissueandcan be exercised at any time to and including30June2012. • The second tranche of 1,400,000 Rightsveston1July2011,provided the performance hurdles set out in theexplanatorymemorandumtothe

• 2009 AGM are met and can be exercised
at
any
time
up
until
30
June 2012.

• Any
 Rights
 that
 remain
 unexercised after
30
June
2012
expire
and
are
no longer
exercisable.

• All
Rights
have
a
nil
exercise
price.

The issue of the Rights was approved by shareholders at the Company’s Annual General
Meeting
on
26
February
2010.

2.
Options

Unlisted
Directors
Options
each
to
subscribe for
one
(1)
ordinary
fully‐paid
share
with
the following
expiry
dates
and
exercise
prices:

• (a) 1,750,000
options
with
an
exercise price
of
$1.00
and
an
expiry
date
of 30
June
2016.

• (b) 1,750,000
options
with
an
exercise price
of
$2.00
and
an
expiry
date
of 30
June
2017;
and

• (c) 1,750,000
options
with
an
exercise price
of
$3.00
and
an
expiry
date
of 30
June
2018.

The
 issue
 of
 the
 Options
 was
 approved
 by shareholders at the Company’s Annual General
Meeting
on
26
February
2010.

+
See
chapter
19
for
defined
terms.

Appendix
3B
Page
2

1/1/2003

4 Dothe +securitiesrankequallyin all respects from the date of allotment with an existing +class ofquoted+securities? If the additional securities do not rankequally,pleasestate: • thedatefromwhichtheydo • the extent to which they participate for the next dividend,(inthecaseofatrust, distribution) or interest payment • theextenttowhichtheydonot rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issuepriceorconsideration 6 Purposeoftheissue (Ifissuedasconsiderationforthe acquisition of assets, clearly identifythoseassets) 7 Datesofentering+securitiesinto uncertificated holdings or despatchofcertificates 8 Number and +class of all +securities quoted on ASX (including the securities in clause2ifapplicable)	1.Rights No.Priortoexercise,theRightsdonotcarry the right to vote, receive dividends, or generally participate in other corporate actions.However,incertaincircumstances, thenumberofSharesunderlyingtheRights will be appropriately adjusted as required under the ASX Listing Rules from time to time. 2.Options No. Prior to exercise, the Options do not carrytherighttovote,receivedividends,or generally participate in other corporate actions.However,incertaincircumstances, the exercise price or the number of shares underlying the option will be appropriately adjusted as required under the ASX Listing Rulesfromtimetotime.	1.Rights No.Priortoexercise,theRightsdonotcarry the right to vote, receive dividends, or generally participate in other corporate actions.However,incertaincircumstances, thenumberofSharesunderlyingtheRights will be appropriately adjusted as required under the ASX Listing Rules from time to time. 2.Options No. Prior to exercise, the Options do not carrytherighttovote,receivedividends,or generally participate in other corporate actions.However,incertaincircumstances, the exercise price or the number of shares underlying the option will be appropriately adjusted as required under the ASX Listing Rulesfromtimetotime.
	Nil.
	TheRightsandOptionsareissuedunderthe Company’sDirectorandExecutiveEquity Plan(aplanapplyingtocertaindirectorsand executivesoftheCompanyandits subsidiaries).
	7July2010
	Number	+Class
	63,205,517	Ordinary fully paid shares
	Number	+Class

9 Number and +class of all +securities not quoted on ASX (including the securities in clause2ifapplicable)	200,000 200,000 600,000 300,000 300,000 100,000 195,000 149,000 3,000,000 13,714	Directoroptions exercisableat$3.75 Directoroptions exercisableat$5.00 Directoroptions exercisableat$3.75 CEOoptions exercisableat$3.00 CEOoptions exercisableat$3.75 Optionsexercisable at$3.75andexpiring on18January2011 Optionsexercisable at$3.75andexpiring on19January2011 Optionsexercisable at$3.00andexpiring on20January2011 CBOptions exercisableat$4.00 andexpiringon 19February2013 Convertiblenotesat anissuepriceof $1,000per convertiblenote

+
See
chapter
19
for
defined
terms.

Appendix
3B
Page
4

1/1/2003

5,241,000 150,000 2,880,000 1,750,000 1,750,000 1,750,000	Convertible Notes at an issue price of $1.00perconvertible note Options exercisable at $1.00 expiring on 29March2011. Rights under the Company’s Director andExecutiveEquity Plan Directors options exercisable at $1.00 and expiring on 30 June2016. Directors options exercisable at $2.00 and expiring on 30 June2017. Directors options exercisable at $3.00 and expiring on 30 June2018.

10 Dividend
policy
(in
the
case
of
a NA trust,
distribution
policy)
on
the increased
capital
(interests)

Part
2
­

Bonus
issue
or
pro
rata
issue

• 11 Is security holder approval N/A required?

• 12 Is
 the
 issue
 renounceable
 or
 non‐ N/A renounceable?

• 13 Ratio
 in
 which
 the[+] securities
 will N/A be
offered

• 14 +Class
 of +securities
 to
 which
 the N/A offer
relates

• 15 +Record date to determine N/A entitlements

16 Willholdingsondifferentregisters (orsubregisters)beaggregatedfor calculatingentitlements? 17 Policy for deciding entitlements in relationtofractions 18 Names of countries in which the entity has +security holders who will not be sent new issue documents Note: Security holders must be told how their entitlementsaretobedealtwith. Crossreference:rule7.7. 19 Closing date for receipt of acceptancesorrenunciations 20 Namesofanyunderwriters 21 Amountofanyunderwritingfeeor commission 22 Namesofanybrokerstotheissue 23 Fee or commission payable to the brokertotheissue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalfof+securityholders 25 If the issue is contingent on +security holders’ approval, the dateofthemeeting 26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent topersonsentitled 27 Iftheentityhasissuedoptions,and thetermsentitleoptionholdersto participateonexercise,thedateon whichnoticeswillbesenttooption holders 28 Date rights trading will begin (if applicable)	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A
	N/A

+
See
chapter
19
for
defined
terms.

Appendix
3B
Page
6

1/1/2003

29 Date rights trading will end (if applicable) 30 Howdo+securityholdersselltheir entitlements in full through a broker? 31 Howdo+securityholderssell_part_ of their entitlements through a brokerandacceptforthebalance? 32 How do +security holders dispose of their entitlements (except by salethroughabroker)? 33 +Despatchdate	N/A
	N/A
	N/A
	N/A
	N/A

Part
3
­
Quotation
of
securities

You
need
only
complete
this
section
if
you
are
applying
for
quotation
of
securities

34 Type
of
securities ( tick
one ) (a) Securities
described
in
Part
1 (b) All
other
securities Example:
 restricted
 securities
 at
 the
 end
 of
 the
 escrowed
 period,
 partly
 paid
 securities
 that
 become
 fully
 paid, employee
incentive
share
securities
when
restriction
ends,
securities
issued
on
expiry
or
conversion
of
convertible securities

Entities
that
have
ticked
box
34(a)

Additional
securities
forming
a
new
class
of
securities

Tick
to
indicate
you
are
providing
the
information
or documents

35		Ifthe+securitiesare+equitysecurities,thenamesofthe20largestholdersofthe
		additional +securities, and the number and percentage of additional +securities
heldbythoseholders 36 Ifthe +securitiesare +equitysecurities,adistributionscheduleoftheadditional
		+securitiessettingoutthenumberofholdersinthecategories
		1‐1,000
		1,001‐5,000
		5,001‐10,000
		10,001‐100,000
		100,001andover

37 A
copy
of
any
trust
deed
for
the
additional[+] securities

Entities
that
have
ticked
box
34(b)

38 Number of securities for which N/A +quotation
is
sought 39 Class of +securities for which N/A quotation
is
sought 40 Do
the[+] securities
rank
equally
in N/A all respects from the date of allotment
 with
 an
 existing[+] class of
quoted[+] securities? If
 the
 additional
 securities
 do
 not rank
equally,
please
state: • the
date
from
which
they
do • the extent to which they participate for the next dividend,
(in
the
case
of
a
trust, distribution) or interest payment • the
extent
to
which
they
do
not rank equally, other than in relation
 to
 the
 next
 dividend, distribution or interest payment 41 Reason
 for
 request
 for
 quotation N/A now Example:
In
the
case
of
restricted
securities,
end of
restriction
period (if issued upon conversion of another security, clearly identify that
other
security) Number +Class 42 Number and +class of all N/A +securities quoted on ASX ( including the
 securities
 in
 clause 38)

+
See
chapter
19
for
defined
terms.

Appendix
3B
Page
8

1/1/2003

Quotation
agreement

• 1 +Quotation
 of
 our
 additional
 +securities
 is
 in
 ASX’s
 absolute
 discretion.
 
 ASX may
quote
the[+] securities
on
any
conditions
it
decides.

• 2 We
warrant
the
following
to
ASX.

• The
issue
of
the[+] securities
to
be
quoted
complies
with
the
law
and
is not
for
an
illegal
purpose.

• There is no reason why those[+] securities should not be granted +quotation.

• An
offer
of
the[+] securities
for
sale
within
12
months
after
their
issue will
not
require
disclosure
under
section
707(3)
or
section
1012C(6)
of the
Corporations
Act.

Note:
An
entity
may
need
to
obtain
appropriate
warranties
from
subscribers
for
the
securities
in
order
to
be
able to
give
this
warranty

• Section
724
or
section
1016E
of
the
Corporations
Act
does
not
apply
to any
 applications
 received
 by
 us
 in
 relation
 to
 any[+] securities
 to
 be quoted
 and
 that
 no‐one
 has
 any
 right
 to
 return
 any[+] securities
 to
 be quoted
under
sections
737,
738
or
1016F
of
the
Corporations
Act
at
the time
that
we
request
that
the[+] securities
be
quoted.

• If
we
are
a
trust,
we
warrant
that
no
person
has
the
right
to
return
the +securities
to
be
quoted
under
section
1019B
of
the
Corporations
Act
at the
time
that
we
request
that
the[+] securities
be
quoted.

• 3 We
will
indemnify
ASX
to
the
fullest
extent
permitted
by
law
in
respect
of
any claim,
 action
 or
 expense
 arising
 from
 or
 connected
 with
 any
 breach
 of
 the warranties
in
this
agreement.

• 4 We
 give
 ASX
 the
 information
 and
 documents
 required
 by
 this
 form.
 
 If
 any information or document not available now, will give it to ASX before +quotation
of
the
+securities
begins.

We
acknowledge
that
ASX
is
relying
on
the information
 and
 documents.
 
 We
 warrant
 that
 they
 are
 (will
 be)
 true
 and complete.

Sign
here: ............................................................






Date: Director/Company
secretary

Print
name:

==
==
==
==
==

+
See
chapter
19
for
defined
terms.

24/10/2005

Appendix
3B
Page
9